GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palatin Technologies Inc (LTS:0KF3) » Definitions » Shiller PE Ratio

Palatin Technologies (LTS:0KF3) Shiller PE Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Palatin Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Palatin Technologies Shiller PE Ratio Historical Data

The historical data trend for Palatin Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palatin Technologies Shiller PE Ratio Chart

Palatin Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Palatin Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Palatin Technologies's Shiller PE Ratio

For the Biotechnology subindustry, Palatin Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Palatin Technologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palatin Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Palatin Technologies's Shiller PE Ratio falls into.



Palatin Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Palatin Technologies's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Palatin Technologies's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.53/131.7762*131.7762
=-0.530

Current CPI (Mar. 2024) = 131.7762.

Palatin Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -1.000 100.560 -1.310
201409 0.250 100.428 0.328
201412 0.750 99.070 0.998
201503 -1.750 99.621 -2.315
201506 -2.500 100.684 -3.272
201509 -2.000 100.392 -2.625
201512 -2.000 99.792 -2.641
201603 -2.000 100.470 -2.623
201606 -2.000 101.688 -2.592
201609 -2.000 101.861 -2.587
201612 -1.500 101.863 -1.940
201703 -0.500 102.862 -0.641
201706 2.000 103.349 2.550
201709 1.250 104.136 1.582
201712 0.250 104.011 0.317
201803 -0.094 105.290 -0.118
201806 1.250 106.317 1.549
201809 -0.750 106.507 -0.928
201812 -0.500 105.998 -0.622
201903 -0.750 107.251 -0.922
201906 6.000 108.070 7.316
201909 -0.500 108.329 -0.608
201912 -0.500 108.420 -0.608
202003 -0.500 108.902 -0.605
202006 -0.750 108.767 -0.909
202009 -0.500 109.815 -0.600
202012 -1.000 109.897 -1.199
202103 -0.500 111.754 -0.590
202106 -1.500 114.631 -1.724
202109 -0.750 115.734 -0.854
202112 -0.910 117.630 -1.019
202203 -0.800 121.301 -0.869
202206 -1.340 125.017 -1.412
202209 -0.860 125.227 -0.905
202212 0.250 125.222 0.263
202303 -0.760 127.348 -0.786
202306 -1.190 128.729 -1.218
202309 -0.480 129.860 -0.487
202312 -0.560 129.419 -0.570
202403 -0.530 131.776 -0.530

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Palatin Technologies  (LTS:0KF3) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Palatin Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Palatin Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Palatin Technologies (LTS:0KF3) Business Description

Traded in Other Exchanges
Address
4B Cedar Brook Drive, Cranbury, NJ, USA, 08512
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Palatin Technologies (LTS:0KF3) Headlines

No Headlines